In this role, you will define and execute agreed sales strategies within a given geographical territory. Expected to propect, genere, nurture and grow business within a defined clinical vertical. Focusing on: hospitals, clinical diagnostics, and related healthcare professions. For each subvertical, you will identify business potential and in doing so, build long term business relationships with key decision makers in order to expand and enrich our current client base in your assigned territory.
We are looking for an experienced professional with a commercial mindset, a strong work-ethic, and innovative attitude. You will have at least 3 years experience in managing key territories ability to work independently and demonstrate a history of exceeding established sales targets.
In order to be successful in this role, we expect you to be able to rapidly assimilate and practically apply medical and scientific information pertaining to clinical diagnostics. Moreover, you will have experience in presenting in front of groups of professionals at CSO/CEO level.
Strong verbal and written communication skills in English French and German is required.
On a day-to-day basis, you will:
We are looking for people who have:
ABOUT NEOTERYX
Founded in 2014, Neoteryx is a medical device company shaping the future of healthcare. Our breakthrough blood collection technology – VAMS™ – is used by pharmaceutical giants, organ transplant patients, researchers in economically disadvantaged regions, and others on the leading edge of science and medicine. When you join our fun, tight-knit team, you’ll discover what one drop of blood can do, and be part of microsampling innovations that will change the world.
Watch this video to learn more!
Contact Us
Trajan Scientific Americas Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine.
In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group.
Copyright © 2022. All rights reserved.